VEGFA (VEGF)
|
7422 |
Human |
9606 |
siRNA HIF1A/EPAS1 |
Renal carcinoma RCC4 and 786-O (no VHL function) |
[54] |
VEGFA (VEGF)
|
7422 |
Human |
9606 |
DNA microarray and northern blot |
Renal carcinoma 786-O (no HIF1A) and HEK293 TET-on cells |
[55] |
VEGFA (VEGF)
|
7422 |
Human |
9606 |
siRNA HIF1A/EPAS1, ELISA |
Renal carcinoma RCC4 and SKRC28 |
[56] |
SLC2A1 (GLUT1)
|
6513 |
Human |
9606 |
siRNA HIF1A/EPAS1 |
Renal carcinoma RCC4 and 786-O (no VHL function) |
[54] |
SLC2A1 (GLUT1)
|
6513 |
Human |
9606 |
Overexpression of HIF1A/EPAS1, immunoblotting |
Renal carcinoma 786-O, RCC4 and SKRC28 |
[56] |
PLAUR (uPAR)
|
5329 |
Human |
9606 |
siRNA HIF1A/EPAS1 |
Renal carcinoma RCC4 and 786-O (no VHL function) |
[54] |
SERPINE1 (PAI-1)
|
5054 |
Human |
9606 |
siRNA HIF1A/EPAS1 |
Renal carcinoma RCC4 and 786-O (no VHL function) |
[54] |
CCND1 (cyclin D1) |
595 |
Human |
9606 |
siRNA HIF1A/EPAS2, overexpression of HIF1A/EPAS1, immunoblotting |
Renal carcinoma 786-O |
[56] |
BNIP3
|
664 |
Human |
9606 |
Overexpression of HIF1A/EPAS1, immunoblotting |
Renal carcinoma 786-O, RCC4 and SKRC28 |
[56] |
TGFA
|
7039 |
Human |
9606 |
siRNA HIF1A/EPAS1, ELISA |
Renal carcinoma RCC4 and SKRC28 |
[56] |
PLIN2 (ADRP)
|
123 |
Human |
9606 |
DNA microarray and northern blot |
Renal carcinoma 786-O (no HIF1A) and HEK293 TET-on cells |
[55] |
NDRG1
|
10397 |
Human |
9606 |
DNA microarray and northern blot |
Renal carcinoma 786-O (no HIF1A) and HEK293 TET-on cells |
[55] |
ADM
|
133 |
Human |
9606 |
DNA microarray and northern blot |
Renal carcinoma 786-O (no HIF1A) and HEK293 TET-on cells |
[55] |
DNMT1
|
1786 |
Human |
9606 |
ChIP-qPCR, Luciferase assay |
Lung cancer cell lines, HEK293 cells |
[37] |
EPO
|
3415 |
Mouse Human |
10090 9606 |
Cre-mediated inactivation of HIF1A/EPAS1 in mice and siRNA in cell lines, RT-PCR, ChIP |
Mice liver tissue and liver Hep3B cells |
[57] |
EPO
|
3415 |
Human |
9606 |
siRNA HIF1A/EPAS1, immunoblotting, RNase protection assay |
Liver Hep3B cells and neuroblastoma Kelly cells |
[58] |